The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/alzheimer-antibody-therapy-denied-approval-scotland-2026a100045o?src=rss
Author :
Publish date : 2026-02-10 12:31:00
Copyright for syndicated content belongs to the linked Source.